StockData
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX) stock

BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.38−0.22 (-2.29%)

Close on Nov 18, 2026Market cap $620.70MP/E –Yield –

Bicara Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Bicara Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 2.5× a year earlier. Over the last 2 years it ranged from 1.1× to 3.8×, with a median of 2.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×−0.8
2025Dec 31, 20252.3×+0.4
2024Dec 31, 20241.9×–

More Bicara Therapeutics figures

See a number that looks wrong?